PharmaCielo(OTC) PCLOF

Market Cap$8.21M

Since IPO (2019)-99%

5 Year-96%

1 Year+80%

1 Month-24%

$0.04

-8.47%

-0.00Today

PharmaCielo last closing stock price
Metric	Price	Date
Last close	USD 0.04	2026-08-28

PharmaCielo stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-23.07%	USD 0.05	2026-08-21
1 month	-23.54%	USD 0.05	2026-07-29
3 month	-40.23%	USD 0.07	2026-05-29
Year to date	+4.52%	USD 0.04	2025-12-30
1 year	+80%	USD 0.02	2025-08-28
3 year	-67.45%	USD 0.12	2023-08-29
5 year	-95.89%	USD 0.95	2021-08-27
Since inception	-99.44%	USD 6.99	2019-01-28

PharmaCielo Financials at a Glance

Market Cap

$8.21M

Revenue (TTM)

CA$3.61M

Net Income (TTM)

-CA$3.72M

EPS (TTM)

-$0.01

P/E Ratio

-2.88

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$0.04

Volume

36,369

Open

$0.04

Price

$0.04

Volume

36,369

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.05

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

Jul 30, 2026

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$0.04

Volume

36,369

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.05

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

Jul 30, 2026

PCLOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCielo

PharmaCielo Ltd. specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including THC. The company also offers telemedicine software solutions, serving a diverse clientele across Canada and Colombia.

Products and Services

Medical-grade cannabis extracts, including THC
Telemedicine software solutions for healthcare providers
Partnerships with health and wellness product manufacturers

Growth Outlook

Strategic alliances enhance market reach and operational capabilities
Expanding clientele in health, wellness, and cosmetic sectors
Increasing demand for medical cannabis products in North America

Financial Highlights

Recent quarterly revenue of 720,370 CAD, showing growth potential
Trailing twelve months (TTM) revenue of 2,507,000 CAD
Net income for Q4 2025 was 407,076 CAD, indicating profitability

PharmaCielo Ltd. operates in the rapidly growing cannabis industry, focusing on high-quality medical-grade products. The company has established a strong presence in both Canada and Colombia, leveraging strategic partnerships to enhance its market position. Recent financial performance indicates a positive trajectory, with increasing revenue and a return to profitability in the latest quarter. The expanding demand for cannabis products, coupled with innovative telemedicine solutions, positions PharmaCielo Ltd. as a noteworthy player in the healthcare sector.

AI Generated • Aug 9, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Marc Lustig, MBA

Website

www.pharmacielo.com

Headquarters

Toronto, ON M5C 1P1, CA

PCLOF Financials

Key Financial Metrics (TTM)

Gross Margin

37.20%

Operating Margin

-82.00%

Net Income Margin

-103.08%

Return on Equity

28.59%

Return on Capital

-117.01%

Return on Assets

-29.14%

Earnings Yield

-34.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.21M

Shares Outstanding

211.28M

Volume

36.37K

Avg. Volume

55.25K

Financials (TTM)

Gross Profit

CA$1.22M

Operating Income

-CA$2.96M

EBITDA

-CA$427.33K

Operating Cash Flow

-CA$6.97M

Capital Expenditure

CA$7.12

Free Cash Flow

-CA$6.97M

Cash & ST Invst.

CA$77.53K

Total Debt

CA$18.22M

PharmaCielo Performance Analysis

PharmaCielo annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-12-31	CAD 1,142,301	-72.0%
2024	2024-12-31	CAD 2,540,069	122.4%
2025	2025-03-31	CAD 2,281,423	-10.2%
2026	2026-03-31	CAD 1,835,064	-19.6%

PharmaCielo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	175.4%
Q4	2025-12-31	-31.9%
Q1	2026-03-31	18.9%
Q2	2026-06-30	93.1%

PharmaCielo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-12-31	CAD -0.08	2.0%
2024	2024-12-31	CAD -0.04	-48.3%
2025	2025-03-31	CAD -0.05	20.3%
2026	2026-03-31	CAD -0.01	-70.8%

PharmaCielo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-45.1%
Q4	2025-12-31	129.7%
Q1	2026-03-31	-400.0%
Q2	2026-06-30	-6.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

CA$1.39M

+330.9%

Gross Profit

CA$603.66K

+4614.2%

Gross Margin

43.41%

N/A

Market Cap

$8.21M

N/A

Market Cap/Employee

$30.65K

N/A

Employees

268

N/A

Net Income

-CA$1.44M

-43.9%

EBITDA

-CA$351.99K

+50.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

CA$77.53K

+1084.6%

Total Debt

CA$18.22M

-12.5%

Accounts Receivable

CA$1.06M

+44.7%

Inventory

CA$1.75M

+16.5%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$18.22M

-12.5%

Return on Assets

-29.14%

N/A

Return on Invested Capital

27.62%

N/A

Free Cash Flow

-CA$227.96K

-110.8%

Operating Cash Flow

-CA$227.96K

-110.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVTBFAvant Brands Inc.

AVTBFAvant Brands Inc.$0.45-2.08%

BBRRFBlueberries Medical Corp.

BBRRFBlueberries Medical Corp.$0.01+0.00%

CPIVFCaptiva Verde Wellness Corp.

CPIVFCaptiva Verde Wellness Corp.$0.04+0.00%

BUDZWEED, Inc.

BUDZWEED, Inc.$0.03+0.33%

CANNTrees Corporation

CANNTrees Corporation$0.02-6.59%

THCBFTHC Biomed Intl Ltd.

THCBFTHC Biomed Intl Ltd.$0.00+0.00%

AUSAFAustralis Capital Inc.

AUSAFAustralis Capital Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$217.55-0.05%

PCGPG&E

PCGPG&E$16.60-0.08%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.45-0.03%

IRENIren

IRENIren$35.45-0.13%

INTCIntel

INTCIntel$89.47-0.03%

NUNu Holdings

NUNu Holdings$14.30-0.04%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.90-0.03%

Questions About PCLOF

What is the current price of PharmaCielo?

PharmaCielo is trading at $0.04 per share.

What is the 52-week range for PharmaCielo?

Over the past 52 weeks, PharmaCielo has traded between $0.00 and $0.12.

How much debt does PharmaCielo have?

As of the most recent reporting period, PharmaCielo reported total debt of CA$12.84M.

How much cash does PharmaCielo have on hand?

PharmaCielo reported CA$54.62K in cash and cash equivalents in its most recent financial results.

What is PharmaCielo’s dividend yield?

PharmaCielo does not currently have a dividend yield.

PharmaCielo(OTC) PCLOF

PharmaCielo Financials at a Glance

PCLOF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PharmaCielo

PCLOF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PharmaCielo Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PCLOF

What is the current price of PharmaCielo?

What is the 52-week range for PharmaCielo?

How much debt does PharmaCielo have?

How much cash does PharmaCielo have on hand?

What is PharmaCielo’s dividend yield?

Premium Investing Services